Paradiso A - Search Results

1

Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.

De Lena M, Brandi M, Logroscino A, Lorusso V, Paradiso A, Maiello E. De Lena M, et al. Among authors: paradiso a. Tumori. 1988 Feb 29;74(1):57-63. doi: 10.1177/030089168807400110. Tumori. 1988. PMID: 3162624

2

Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.

De Lena M, Tommasi S, Schittulli F, Lorusso V, Paradiso A. De Lena M, et al. Among authors: paradiso a. Tumori. 1990 Apr 30;76(2):190-5. doi: 10.1177/030089169007600208. Tumori. 1990. PMID: 2139523 Clinical Trial.

3

M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinoma.

Lorusso V, Berardi F, Brandi M, Mastria A, Paradiso A, Catino AM, Tatulli C, De Lena M. Lorusso V, et al. Among authors: paradiso a. Tumori. 1993 Jun 30;79(3):191-4. doi: 10.1177/030089169307900306. Tumori. 1993. PMID: 8236502 Clinical Trial.

4

Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.

Lorusso V, Mancarella S, Catino A, Brandi M, Paradiso A, Latorre A, Mastria A, De Mitrio A, Guida M, De Lena M. Lorusso V, et al. Among authors: paradiso a. Tumori. 1999 Jan-Feb;85(1):60-4. doi: 10.1177/030089169908500113. Tumori. 1999. PMID: 10228500

5

Different assays for HER-2/neu evaluation in breast cancer.

Tommasi S, Paradiso A, Serio G, Barletta A, Mangia A, Giannella C, De Lena M. Tommasi S, et al. Among authors: paradiso a. Tumori. 1992 Apr 30;78(2):106-10. doi: 10.1177/030089169207800208. Tumori. 1992. PMID: 1355935

6

Ifosfamide plus mitoxantrone as salvage treatment in non-Hodgkin's lymphomas.

Lorusso V, Paradiso A, Guida M, Berardi F, De Lena M. Lorusso V, et al. Among authors: paradiso a. Am J Clin Oncol. 1991 Dec;14(6):492-5. doi: 10.1097/00000421-199112000-00007. Am J Clin Oncol. 1991. PMID: 1957837

7

Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.

Paradiso A, Tommasi S, Mangia A, Lorusso V, Simone G, De Lena M. Paradiso A, et al. Cancer Res. 1990 May 15;50(10):2958-62. Cancer Res. 1990. PMID: 2334898

8

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

Paradiso A, Tommasi S, Brandi M, Marzullo F, Simone G, Lorusso V, Mangia A, De Lena M. Paradiso A, et al. Cancer. 1989 Nov 1;64(9):1922-7. doi: 10.1002/1097-0142(19891101)64:9<1922::aid-cncr2820640927>3.0.co;2-i. Cancer. 1989. PMID: 2790702

9

Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer.

Paradiso A, Lorusso V, Tommasi S, Schittulli F, Maiello E, De Lena M. Paradiso A, et al. Breast Cancer Res Treat. 1988 Apr;11(1):31-6. doi: 10.1007/BF01807555. Breast Cancer Res Treat. 1988. PMID: 3382761

10

Immunoglobulin heavy chain gene rearrangement in B-cell non-Hodgkin's lymphomas detected by the polymerase chain reaction.

Alaibac M, Paradiso A, Giannella C, Labriola A, Marzullo F, Lorusso V, De Lena M. Alaibac M, et al. Among authors: paradiso a. Tumori. 1995 Mar-Apr;81(2):128-31. doi: 10.1177/030089169508100211. Tumori. 1995. PMID: 7778215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters